Xuanzhu Biopharmaceutical Co Ltd Sustainability Reports
The company operates as a clinical-stage biopharmaceutical enterprise that develops, produces, and commercializes innovative small-molecule and macromolecular drugs focusing on oncology, digestive, and metabolic diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01X2RVC76
2 reports from 2025 to 2025
